-FAO The world's forests have a major role to play in the transition to a new, greener economy, a theme being discussed at the Rio+20 Conference. But to spark that shift, governments must enact programs and policies aimed at both unlocking the potential of forests and ensuring that they are sustainably managed, FAO said today. In a new report, The State of the World's Forests 2012 (SOFO 2012), the UN Food and...
More »SEARCH RESULT
Dr Edgar A Whitley, Reader in the Information Systems and Innovation Group at the LSE interviewed by Baba Umar
In 2005, when the Labour Party decided to implement the National Identity Project (NIP) in the UK, it drew severe criticism from many quarters, including the Tories, who later scrapped the NIP after coming to power. A report by the London School of Economics (LSE), which stated the project is “unsafe in law” and should be regarded as a “potential danger to public interest”, was instrumental in buttressing the arguments...
More »Patent to plunder -Amit Sengupta
India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...
More »Need for new TB drugs
-The Hindu Public sector participation in discovering, developing and making a drug available at affordable prices may be the only way to find new cures for diseases like TB, says Pof Samir Brahmachari on the occasion of World Tuberculosis Day Tuberculosis (TB), a raging problem in Europe and Americas till early 20 century, now predominantly affects the developing world where it continues to be a major health problem and is making in...
More »India's patent ruling on cancer may open door for cheaper HIV drugs
-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say. On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...
More »